CABR Caring Brands, Inc.
Price Chart
Executive Summary
Caring Brands announced an expanded multi-territory licensing agreement with SanPellegrino Cosmetics for Photocil and Hair Enzyme Booster, extending the term to five years with automatic renewal and adding LATAM, Russia, Australia, and New Zealand to the existing India territory. No financial terms, revenue figures, or guidance were disclosed, making this a routine commercial development for a micro-cap with no quantifiable impact.
Actionable Insight
Monitor upcoming 10-Q for any disclosed licensing revenue or milestone payments tied to this expanded agreement. Without financial terms, the near-term revenue impact is speculative; the stock's micro-cap status means modest contract news can move the stock, but the lack of hard numbers limits conviction.
Key Facts
- Agreement effective May 21, 2026, with a five-year initial term and automatic annual renewal.
- Expanded territory now covers India (existing), LATAM (Mexico, Brazil, Colombia, Ecuador, Peru, Dominican Republic, Trinidad and Tobago), Russia, Australia, and New Zealand.
- Products: Photocil (vitiligo, psoriasis, atopic dermatitis) and Hair Enzyme Booster (adjunct to minoxidil).
- SCPL sub-license partners include Eris Lifesciences (India), Glenmark Pharmaceuticals (Asia/Middle East), and has registered or is in regulatory review across Malaysia, Vietnam, Cambodia, UAE, Kuwait, Saudi Arabia.
- No financial terms, revenue contributions, or milestones were disclosed in the press release.
Financial Impact
No financial figures disclosed.
Risk Factors
- No financial terms disclosed — revenue contribution is uncertain.
- Micro-cap stock with $10M market cap is highly sensitive to any news flow, but this is a routine commercial update.
- Forward-looking statements about future revenue streams are unsubstantiated by specific guidance.
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-026533 |
| Exhibit: ex99-1.htm | 0001493152-26-026533 |
| Document: 0001493152-26-026533-index-headers.html | 0001493152-26-026533 |
| Document: 0001493152-26-026533-index.html | 0001493152-26-026533 |
| Document: 0001493152-26-026533.txt | 0001493152-26-026533 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 1, 2026
3d ago
|
DEFA14A
| — | awaiting T+1 | — | — |
|
Jun 1, 2026
4d ago
|
8-K
| $1.30 $1.25 | ▼ −4.23% | ▼ −4.38% | $1.30 (−0.00%) |
|
May 29, 2026
6d ago
|
8-K
| — | awaiting T+1 | — | — |
|
May 15, 2026
21d ago
|
EFFECT
| — | awaiting T+1 | — | — |
|
Apr 10, 2026
7w ago
|
8-K
| $1.12 $1.17 | ▼ −4.46% | ▼ −3.25% | $1.30 (−16.07%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access